Novo Nordisk A/SNVONYSE
Loading
Operating Margin Over TimeStable
Percentile Rank71
3Y CAGR+1.1%
5Y CAGR+0.5%
Year-over-Year Change
Operating income as a percentage of revenue
3Y CAGR
+1.1%/yr
vs +0.0%/yr prior
5Y CAGR
+0.5%/yr
Consistent
Acceleration
+1.1pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 43.69% | -1.1% |
| 2024 | 44.19% | +0.1% |
| 2023 | 44.16% | +4.5% |
| 2022 | 42.28% | +1.5% |
| 2021 | 41.65% | -2.3% |
| 2020 | 42.64% | -0.9% |
| 2019 | 43.01% | +1.8% |
| 2018 | 42.25% | -3.6% |
| 2017 | 43.84% | +1.2% |
| 2016 | 43.33% | - |